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The fibroblast growth factors (FGFs) are key regulators of cell growth and differentiation during
embryogenesis. They deliver both short-range and distant signals assisted by their proteoglycan
(PG) coreceptors in the pericellular matrix. The study by Hou et al. (2007) has identified a novel auto-
inductive loop involving FGF and the secreted serine protease xHtrA1 that leads to themobilization of
latent FGF/PG complexes. These complexes are long-range messages for mesoderm induction and
establishment of the embryonic body plan.
Despite their high-profile appearance
at the cell surface and in the extracellu-
lar matrix (ECM), proteoglycans (PGs)
are rather sensitive creatures, readily
clipped by proteases that may activate
a latent function or initiate
PG turnover during remod-
eling of the ECM in embryo-
genesis and postnatal
growth. It has been known
for many years that PGs are
mandatory coreceptors for
many embryonic growth
factors such as the FGFs,
hepatocyte growth factor/
scatter factor, and vascular
endothelial growth factor
(Bulow and Hobert, 2006;
Bishop et al., 2007) and
that they regulate diffusion
gradients of wingless and
hedgehog and other mor-
phogenic proteins (Lin and
Perrimon, 2000). Although
most attention has been
focused on the coreceptor
functions of the heparan
sulfate PGs (the major cell
surface PGs), it is now
becoming clear that PGs
containing dermatan sulfate
(DS) and highly sulfated,
hybrid dermatan/chondroitin
glycosaminoglycan (GAG)
chains also participate in
growth factor signaling (Tay-
lor et al., 2005), especially
in the embryonic nervous
system (Li et al., 2007) In
this publication, Pera and
coworkers (Hou et al.,
2007) have identified an intriguing
positive feedback loop in Xenopus
embryos between the FGFs and a
secreted serine protease xHtrA1. This
protease attacks the core proteins of
several PGs, and the data suggest
a role for fragmented PGs as carriers
of FGF signals through the embryonic
matrix. Similarities in spatiotemporal
expression of XHtrA1 and FGFs and
close parallels in the pheno-
typic effects of knockdown
and overexpression of these
early embryonic genes indi-
cated that they act in com-
mon developmental path-
ways. Moreover, flg-tagged
constructs ofPGs expressed
in Drosophila embryos re-
vealed that two cell surface
heparan sulfate PGs, Syn-
decan 4 and Glypican 4,
and the ECM PG Biglycan,
were potential substrates
for xHtrA1. In principle, all
three PGs could bind FGFs
on their covalently linked
glycosaminoglycan (GAG)
side chains, and the FGF-
PG complexes, released
from their membrane or ECM
attachment sites by xHtrA1,
would then be free to diffuse
to distant targets. The ques-
tion is whether all three
cleaved PGs can deliver the
FGF signal (or signals). Al-
though this question is not
directly addressed in the pa-
per, and the authors rightly
keep an open mind on the is-
sue, there are some pointers
in the data and in the pub-
lished literature to suggest
that this critical task may
be assigned to Biglycan.
Figure 1. Proteoglycans in the Drosophila Embryo: Potential
Targets of the Developmentally Regulated xHtrA1 Protease
The xHrtA1 protease releases long-range FGF signals in the form of
growth factor/PG complexes. To do this, the protease must release
PGs from the cell surface (Syndecan and Glypican) or, in the case of
Biglycan, from the ECM. The FGF binds to the GAG chains of PGs,
an interaction that is unlikely to be perturbed by xHrtA1 scission of
the protein cores. The Biglycan protein is a dimer bound to collagen
fibrils. In the Drosophila embryo, its GAG chain is dermatan sulfate
(DS), which is known to bind and activate FGFs. The Syndecans are di-
meric transmembrane PGs (Couchman, 2003), whereas the Glypicans
are retained at the cell surface by a glycolipid GPI) anchor (David,
1993). In the Glypicans, the HS attachment sites are in a short-stem
region of the protein core that links the globular head (blue) to the
GPI domain (black). Heparan sulfate (HS) also binds and activates
the FGFs, but membrane HSPGs must remain on the cell surface to
fulfill their coreceptor functions for the FGFs.166 Developmental Cell 13, August 2007 ª2007 Elsevier Inc.
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PreviewsThe structures of the PGs shown
here to be substrates for xHtrA1 are
depicted diagrammatically in Figure 1.
It is immediately apparent that the
main problem with Glypican 4 as the
FGF messenger is that its heparan sul-
fate (HS) chains are clustered in the
short stem region close to the cell sur-
face. xHtrA1 would have to clip the
Glypican 4 core protein very close to
the membrane surface to release
a freely soluble PG with its HS chains.
Although this cannot be ruled out, the
Syndecan 4 core protein with its HS
positioned distal to the membrane
surface offers a more plausible target
for proteolytic attack. However, the
problem with cell surface PGs acting
as messengers for the FGFs is that
when released from the plasma mem-
brane, they appear unable to function
as coreceptors despite retaining their
FGF-binding capacity. In fact, shed-
ding of cell surface PGs could be a
mechanism for dampening cellular re-
sponses to the FGFs. Active com-
plexes of FGF and HS-saccharides
can be released from Syndecan 1 by
endoheparanase, but if a shed Synde-
can is the endogenous carrier of FGF
signals, the heparanase would have
to be present along its diffusion path,
thus introducing an extra and perhaps
unnecessary regulatory step. This
brings Biglycan into the frame.
Biglycan is a member of the family
of small leucine-rich repeat proteins
and proteoglycans (SLRPS). The SLRP
family is characterized by tandem-
repeats of leucine-rich sequences
flanked by cysteine clusters (McEwan
et al., 2006). Biglycan was so-named
because it normally contains twoGAG chains attached toward the N ter-
minus, in contrast to decorin, the pro-
totypic SLRP, that contains only one.
Both Decorin and Biglycan bind to
the collagenous matrix and participate
in the formation and spacing of col-
lagen fibrils. In common with other
SLRPS, Biglycan has a curved molec-
ular architechture, and in solution it
forms stable head-to tail dimers with
the GAG chains predicted to extend
away from the core of the dimeric as-
sembly (Scott et al., 2006). In this ar-
rangement, the GAG chains are free
to capture and retain soluble protein
effectors. The GAG chain on Biglycan
is always a galactosaminoglycan, ei-
ther chondroitin or dermatan sulfate,
but tellingly, this paper (Hou et al.,
2007) shows that it is glycanated by
dermatan sulfate, the iduronate-bear-
ing isomer that interacts with the
FGFs (Taylor et al., 2005). If Biglycan
is to serve as one of the long-range
messengers of an xHtrA1-dependent
FGF signal, then the protease will
have to release it from its site of attach-
ment to collagen. Proteolytic scission
may be accompanied by dissociation
of the Biglycan dimer, leaving a trun-
cated, monomeric PG free to diffuse
to its target cells. These latter points
are speculative but, as noted by the
authors (Hou et al., 2007), murine
HtrA1 rapidly degrades the Biglycan
core protein (Tocharus et al., 2004); if
this is reproduced in the Drosophila
embryo, it would permit a fast re-
sponse to the controlled release of
endogenous xHtrA1.
In further investigations of long-
range embryonic signaling by FGFs, it
will be important to check whetherDevelopmental Celthe degradation of PGs coincides with
the production of xHrtA1 and to iden-
tify and track the distribution of PG/
FGF complexes. Specific morpholinos
could be used to knockdown expres-
sion of individual PGs to try and pin-
point the principle PG messenger that
is dispatched by xHtrA1. This paper
(Hou et al., 2007) brings a new dimen-
sion to the role of both PGs and de-
velopmentally regulated proteases in
FGF signaling, and the findings may
be relevant to other embryonic growth
factors and morphogens that bind
tightly to the GAG chains of PGs.
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